These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 23225332)
1. Analysis of 20 genes at chromosome band 12q13: RACGAP1 and MCRS1 overexpression in nonsmall-cell lung cancer. Liang Y; Liu M; Wang P; Ding X; Cao Y Genes Chromosomes Cancer; 2013 Mar; 52(3):305-15. PubMed ID: 23225332 [TBL] [Abstract][Full Text] [Related]
2. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway. Liu M; Zhou K; Huang Y; Cao Y J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212 [TBL] [Abstract][Full Text] [Related]
3. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer. Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409 [TBL] [Abstract][Full Text] [Related]
4. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1. Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223 [TBL] [Abstract][Full Text] [Related]
5. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression. Ezponda T; Pajares MJ; Agorreta J; Echeveste JI; López-Picazo JM; Torre W; Pio R; Montuenga LM Clin Cancer Res; 2010 Aug; 16(16):4113-25. PubMed ID: 20682707 [TBL] [Abstract][Full Text] [Related]
6. [Overexpression of miR-21 promotes proliferation and reduces apoptosis in non-small cell lung cancer]. Lan H; Lin CY; Yuan HY; Xiong B Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):742-6. PubMed ID: 22335905 [TBL] [Abstract][Full Text] [Related]
7. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942 [TBL] [Abstract][Full Text] [Related]
8. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues]. Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
10. Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis. Yue W; Zhao X; Zhang L; Xu S; Liu Z; Ma L; Jia W; Qian Z; Zhang C; Wang Y; Yang X Clin Lung Cancer; 2011 Jan; 12(1):43-50. PubMed ID: 21273179 [TBL] [Abstract][Full Text] [Related]
11. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer]. Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma. Wang SM; Ooi LL; Hui KM Clin Cancer Res; 2011 Sep; 17(18):6040-51. PubMed ID: 21825042 [TBL] [Abstract][Full Text] [Related]
13. Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer. Milde-Langosch K; Karn T; Müller V; Witzel I; Rody A; Schmidt M; Wirtz RM Breast Cancer Res Treat; 2013 Jan; 137(1):57-67. PubMed ID: 23135572 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer. Wang ZX; Xue D; Liu ZL; Lu BB; Bian HB; Pan X; Yin YM Int J Biochem Cell Biol; 2012 Jan; 44(1):200-10. PubMed ID: 22064247 [TBL] [Abstract][Full Text] [Related]
15. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells. Sun SY; Yue P; Hong WK; Lotan R Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825 [TBL] [Abstract][Full Text] [Related]
16. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin. Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235 [TBL] [Abstract][Full Text] [Related]
18. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136 [TBL] [Abstract][Full Text] [Related]
19. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis. Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664 [TBL] [Abstract][Full Text] [Related]
20. Deleted in pancreatic carcinoma locus 4/Smad4 participates in the regulation of apoptosis by affecting the Bcl-2/Bax balance in non-small cell lung cancer. Ke Z; Zhang X; Ma L; Wang L Hum Pathol; 2008 Oct; 39(10):1438-45. PubMed ID: 18620728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]